ArticleDrug design, development and therapy2016

Cost-effectiveness comparison of lamivudine plus adefovir combination treatment and nucleos(t)ide analog monotherapies in Chinese chronic hepatitis B patients.

Chi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.